Evidence map›Paper›PMID 29727562›Full record

ArticleJournal of medicinal chemistry2018

N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK632) Promotes Inhibition of BRAF through the Induction of Inhibited Dimers.

Michael Grasso, Michelle A Estrada, Kiara N Berrios, Jeffrey D Winkler, Ronen Marmorstein

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Analyses of the oncogenic BRAFThe Journal of biological chemistry · 2020
    Article
  3. Targeting the ERK Signaling Pathway in Melanoma.International journal of molecular sciences · 2019
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michael GrassoDepartment of Biochemistry and Biophysics and the Abramson Family Cancer Research Institute, Perelman School of Medicine , University of Pennsylvania , 421 Curie Boulevard , Philadelphia , Pennsylvania 19104 , United States.
Michelle A EstradaDepartment of Chemistry , University of Pennsylvania , 231 South 34th Street , Philadelphia , Pennsylvania 19104 , United States.
Kiara N BerriosDepartment of Biochemistry and Biophysics and the Abramson Family Cancer Research Institute, Perelman School of Medicine , University of Pennsylvania , 421 Curie Boulevard , Philadelphia , Pennsylvania 19104 , United States.
Jeffrey D WinklerDepartment of Chemistry , University of Pennsylvania , 231 South 34th Street , Philadelphia , Pennsylvania 19104 , United States.ORCID 0000-0001-8264-5491
Ronen MarmorsteinDepartment of Biochemistry and Biophysics and the Abramson Family Cancer Research Institute, Perelman School of Medicine , University of Pennsylvania , 421 Curie Boulevard , Philadelphia , Pennsylvania 19104 , United States.ORCID 0000-0003-4373-4752
Cancer Research Institute · USUniversity of Pennsylvania · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
Targeting the MAP and PI3 Kinase Pathways in MelanomaP01CA114046 · NCI · WISTAR INSTITUTE · PI MURPHY, MAUREEN E. · 2008 to 2023
$37.1M
NCI NIH HHS P01 CA114046NCI NIH HHS P30 CA016520
6 · The paper itself

Abstract

BRAF

Indexed as

BenzothiazolesCell Line, TumorDimerizationDrug DesignHumansMAP Kinase Signaling SystemModels, MolecularNitrilesProtein Kinase InhibitorsProtein MultimerizationProtein Structure, QuaternaryProto-Oncogene Proteins B-rafBenzothiazolesNitrilesProtein Kinase InhibitorsProto-Oncogene Proteins B-rafTAK-632

Identifiers

PMID29727562
PMCPMC6540792
OpenAlexW2799501771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.